The primary outcome was the first occurrence of death from CV causes, nonfatal MI (including silent), or nonfatal stroke in patients age 50 years and older with preexisting CV disease, congestive heart failure (CHF) stage II or III, or CKD stage 3 or higher or older than 60 with one or more CV risk factors
Potassium is lost in both vomiting and diarrhoea, and inadequate dietary intake due to reduced appetite compounds this loss
Genetics, lifestyle factors, and concurrent use of other medications can influence how a person reacts to the drug, including its effects on sleep
Previous studies have demonstrated the promoting effect of BPC 157 on the healing of different tissues, including skin, mucosa, cornea, muscle, tendon, ligament and bone in animal studies [14,15,16,17,18,19,20,21,22,23,24]